Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

56.83 USD UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Dec 6, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10
Open 56.83
Bid (Size) 56.00 (1)
Ask (Size) 57.10 (5)
Prev. Close 56.83
Today's Range 56.83 - 56.83
52wk Range 53.22 - 69.75
Shares Outstanding 2,222,113,553
Dividend Yield 3.45%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Tomorrow's Innovators: Kwame Sarpong
Tags Bristol/Meyers Squibb Responsible Business & Employee Engagement Diversity & Inclusion
From 3BL Media: Corporate Social Responsibility, Energy and Health News
U.S. Food and Drug Administration Accepts for Priority Review supplemental Biologics License Application for Reblozyl® (luspatercept-aamt) in Adults with Non-Transfusion Dependent (NTD) Beta Thalassem
US FDA Accepts for Priority Review supplemental BLA for Reblozyl® (luspatercept-aamt) in Adults with Non-Transfusion Dependent (NTD) Beta Thalassemia 
From Business Wire News Releases

Performance

YTD
-7.41%
-7.41%
1 Month
-4.34%
-4.34%
3 Month
-12.82%
-12.82%
6 Month
-12.26%
-12.26%
1 Year
-7.14%
-7.14%

More News

Read More
Encouraging Recruitment of Diverse Talent in the Biopharma Industry
Tags NYSE: BMY Responsible Business & Employee Engagement Tunde Bello
From 3BL Media: Corporate Social Responsibility, Energy and Health News
How The Parts Add Up: SPYV Headed For $46
Tags ETFs
From ETF Channel
How Did Healthcare Stocks Perform Over This Volatile Month?
Tags Market News Stocks / Equities Healthcare
From TalkMarkets
A great example of stopping volume on the Bristol-Myers Squibb daily stock chart
Tags Market News Stocks / Equities Healthcare
From TalkMarkets
3 Must-Own Dividend Stocks in This Chaotic Market
Tags Recent Press Releases Market News GSK
From Motley Fool
3 Beaten-Down Dividend Stocks -- Are They Bargins Now?
Tags BMY Market News VTRS
From Motley Fool
Bristol Myers - Merck's Thalassemia Candidate Under FDA Priority Review
Tags Briefs Health Care Biotech
From Benzinga
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
Tags XENE BGNE LLY
From Benzinga
Sunday Memo - Dec. 5
Tags Market News Stocks / Equities
From TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.